Protara Therapeutics has announced encouraging interim results from its ongoing phase 2 STARBORN-1 trial evaluating TARA-002 ...
The European Commission has approved Libtayo (cemiplimab) as the first and only immunotherapy for adult patients with ...
GSK and the Fleming Initiative have announced six new research programmes to combat antimicrobial resistance (AMR), backed by ...
Cellbyte, a Munich-based AI-native platform helping pharmaceutical companies accelerate drug launches, has raised $2.75 ...
Biogen has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has ...
Mursla Bio has announced a new collaboration with a leading global pharmaceutical company to support biomarker-guided drug ...
Scottish Brain Sciences (SBS) has opened a new clinical research centre at ONE BioHub in Aberdeen, marking a significant step forward in early Alzheimer’s research and trial accessibility across ...
Eisai has presented new clinical data from a post-hoc sub-group analysis of the Clarity AD open-label extension for lecanemab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback